Patents

News

Teva and Neos settle over Cotempla patent dispute

Teva and Neos Therapeutics have reached a confidential settlement and licensing agreement that resolves a patent dispute over the Israeli firm's generic version of Neos’ ADHD drug Cotempla XR-OD

Views & Analysis

Will plausibility reign supreme in Lyrica second medical use...

Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.

Views & Analysis

Local partnerships key to pharma’s success in China

China has become more accepting of Western medicines and sees the value of a strong patenting process, opening the door for more foreign trade and mutual benefits.

News